Pre-emptive therapy with cidofovir in adenovirus infection after stem cell transplantation (SCT) in children

被引：0
|
作者：
de Heredia, CD [1 ]
Olivé, T [1 ]
Calicó, I [1 ]
Orlega, JJ [1 ]
机构：
[1] Hosp Gen Valle Hebron, Barcelona, Spain
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [1] Cidofovir (CDV) as prophylaxis and pre-emptive therapy of Cytomegalovirus (CMV) infection in allogeneic stem cell transplantation
    Cudillo, L
    Dentamaro, T
    Postorino, M
    Picardi, A
    Rainaldi, A
    Cupelli, L
    De Laurenzi, F
    Di Caro, A
    Amadori, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S153 - S153
  • [2] Letermovir as Pre-emptive Therapy for Resistant Cytomegalovirus Infection after Allogeneic Stem Cell Transplantation
    Garcia Cereijo, Paula Maria
    Torrado Chedas, Tamara
    Nieto Vazquez, Agustin
    Iglesias Varela, Raquel
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 505 - 506
  • [3] Pre-emptive therapy of CMV infection in allogeneic hematopoietic stem cell transplantation.
    Dentamaro, T
    Cudillo, L
    Picardi, A
    Postorino, M
    Gallone, D
    Masi, M
    Amadori, S
    BONE MARROW TRANSPLANTATION, 1999, 23 : S63 - S63
  • [4] Cidofovir as pre-emptive therapy of cytomegalovirus (CMV) infection after allogeneic transplant.
    Tagliaferri, E
    Soligo, D
    Deliliers, DL
    Della Volpe, A
    Annaloro, C
    Cardone, R
    Deliliers, GL
    BONE MARROW TRANSPLANTATION, 1999, 23 : S67 - S67
  • [5] THE USAGE OF ORAL VALGANCICLOVIR FOR THE PRE-EMPTIVE TREATMENT OF CYTOMEGALOVIRUS INFECTION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN
    Karakukcu, M.
    Isik, B.
    Unal, E.
    Yilmaz, E.
    Mutlu, F. Turkan
    Kirkas, O. Gul
    Ceylan, O.
    Patiroglu, T.
    Ozdemir, M. Akif
    BONE MARROW TRANSPLANTATION, 2014, 49 : S470 - S470
  • [6] Oral valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic stem cell transplantation recipients
    Michael, M.
    Kourti, G.
    Bouzani, M.
    Grispou, O.
    Anagnostopoulou, M.
    Baltathakis, I.
    Apostolidis, I.
    Karakasis, D.
    Harhalakis, N.
    Paniara, O.
    Nikiforakis, E.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S285 - S286
  • [7] Oral valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic stem cell transplantation recipients
    Pastore, D.
    Carluccio, P.
    Gaudio, F.
    Perrone, T.
    Delia, M.
    Albano, F.
    Manduzio, P.
    Fesce, V.
    Mongelli, P.
    Liso, V.
    Specchia, G.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S266 - S267
  • [8] Cytomegalovirus infection: prevalence and pre-emptive therapy in autologous peripheral stem cell transplantation patients
    Bonferroni, M
    Tavera, S
    Castellino, C
    Grasso, M
    Calvi, R
    Mordini, N
    Mattei, D
    Pistone, M
    Raviolo, E
    Gallamini, A
    BONE MARROW TRANSPLANTATION, 2003, 31 : S98 - S98
  • [9] Pre-emptive therapy for adenovirus infection prevents the evolution to disseminated disease in high-risk paediatric patients after allogeneic stem cell transplantation
    Villa, A
    Rossi, MR
    Binda, S
    Primache, V
    Balduzzi, A
    Bonanomi, S
    Rovelli, A
    Uderzo, C
    Longoni, D
    BONE MARROW TRANSPLANTATION, 2005, 35 : S166 - S166
  • [10] A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation
    M A Slavin
    A P Grigg
    A P Schwarer
    J Szer
    A Spencer
    A Sainani
    K A Thursky
    A W Roberts
    Bone Marrow Transplantation, 2007, 40 : 157 - 163
12345